생물학적 제제 안전성 시험 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Biologics Safety Testing Market size is expected to reach USD 19.55 Billion in 2034 from USD 6.08 Billion (2025) growing at a CAGR of 13.86% during 2026-2034.

The global biologics safety testing market is experiencing rapid growth due to the increasing development of biologic drugs, vaccines, and biosimilars. Safety testing is essential to ensure that these products meet strict regulatory standards before reaching the market. The rising prevalence of chronic diseases and the growing demand for advanced therapies have significantly increased the need for biologics, thereby driving demand for safety testing solutions across pharmaceutical and biotechnology industries.

Key drivers include stringent regulatory requirements, increasing research and development activities, and the growing number of clinical trials. The shift toward personalized medicine and targeted therapies has further boosted the importance of biologics safety testing. Additionally, advancements in testing technologies, including automation and rapid detection methods, are improving efficiency and accuracy, making testing processes faster and more reliable.

In the future, the market is expected to grow with continued advancements in biotechnology and regulatory frameworks. The integration of artificial intelligence and digital technologies will enhance testing capabilities and reduce turnaround times. Expanding pharmaceutical industries in emerging markets will create new growth opportunities. As biologics continue to dominate modern therapeutics, the demand for safety testing will remain strong and essential.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product and Services

• Consumables
• Instruments
• Services
• Reagents and kits

By Application

• Vaccine and therapeutics
• Blood and blood-based products
• Gene therapy
• Tissue and tissue-based products
• Stem cells

By Test Type

• Endotoxin tests
• Sterility tests
• Mycoplasma tests
• Bioburden tests
• Residual host-cell proteins and DNA detection tests
• Virus safety tests
• Adventitious agent detection tests
• Other test types

COMPANIES PROFILED

• bioMrieux SA, Charles River Laboratories International Inc, Eurofins Scientific SE, F HoffmannLa Roche Ltd, Lonza Group Ltd, Merck KGaA, Samsung Biologics, Sartorius AG, SGS Socit Gnrale de Surveillance SA, Thermo Fisher Scientific Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL BIOLOGICS SAFETY TESTING MARKET: BY PRODUCT AND SERVICES 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product And Services
• 4.2. Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Reagents and kits Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL BIOLOGICS SAFETY TESTING MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Vaccine and therapeutics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Blood and blood-based products Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Gene therapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Tissue and tissue-based products Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Stem cells Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL BIOLOGICS SAFETY TESTING MARKET: BY TEST TYPE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Test Type
• 6.2. Endotoxin tests Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Sterility tests Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Mycoplasma tests Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Bioburden tests Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Residual host-cell proteins and DNA detection tests Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.7. Virus safety tests Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.8. Adventitious agent detection tests Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.9. Other test types Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL BIOLOGICS SAFETY TESTING MARKET: BY REGION 2022-2034 (USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product And Services
  • 7.2.2 By Application
  • 7.2.3 By Test Type
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product And Services
  • 7.3.2 By Application
  • 7.3.3 By Test Type
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product And Services
  • 7.4.2 By Application
  • 7.4.3 By Test Type
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product And Services
  • 7.5.2 By Application
  • 7.5.3 By Test Type
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product And Services
  • 7.6.2 By Application
  • 7.6.3 By Test Type
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL BIOLOGICS SAFETY TESTING INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 BioMerieux S.A
  • 9.2.2 Charles River Laboratories International Inc
  • 9.2.3 Eurofins Scientific SE
  • 9.2.4 F. Hoffmann-La Roche Ltd
  • 9.2.5 Lonza Group Ltd
  • 9.2.6 Merck KGaA
  • 9.2.7 Samsung Biologics
  • 9.2.8 Sartorius AG
  • 9.2.9 SGS Societe Generale De Surveillance SA
  • 9.2.10 Thermo Fisher Scientific Inc